<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01409720</url>
  </required_header>
  <id_info>
    <org_study_id>DISPO</org_study_id>
    <nct_id>NCT01409720</nct_id>
  </id_info>
  <brief_title>Isometric Muscle Training in Patients With Spinal Bony Metastases Under Radiation Therapy</brief_title>
  <acronym>DISPO</acronym>
  <official_title>Isometric Muscle Training of the Spine Musculature in Patients With Spinal Bony Metastases Under Radiation Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heidelberg University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heidelberg University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Standard indications for palliative radiation of bony metastases include pain, spinal cord
      compression, and impending pathologic fractures.

      Palliative radiation therapy serves to reduce pain, improve quality of life, and avoid
      complications. Tailored training of the paravertebral musculature may support radiation
      therapy and improve above named factors. DISPO was designed to investigate the impact of
      tailored physical exercise in patients with vertebral metastases as compared to manual
      therapy (massage etc.). The trial includes patients with painful bony metastases, patients
      with spinal cord compression or impending pathological fractures are excluded. The
      investigations are carried out in a prospective randomized controlled phase-II parallel group
      design.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Standard indications for palliative radiation of bony metastases include pain, spinal cord
      compression, and impending pathologic fractures.

      Palliative radiation therapy serves to reduce pain, improve quality of life, and avoid
      complications. Tailored training of the paravertebral musculature may support radiation
      therapy and improve above named factors. DISPO was designed to investigate the impact of
      tailored physical exercise in patients with vertebral metastases as compared to manual
      therapy (massage etc.). The trial includes patients with painful bony metastases, patients
      with spinal cord compression or impending pathological fractures are excluded. The
      investigations are carried out in a prospective randomized controlled phase-II parallel group
      design.

      Patients are randomized to one of the following groups: patients in arm A carry out daily
      physical training consisting of three different isometric exercises under the guidance and
      supervision of a physiotherapist. Training starts day one (first radiotherapy session), 10
      daily units of 30 min each are scheduled during radiotherapy. Patients are expected to
      continue training until 12 weeks post completion of radiotherapy at home.

      Patients in arm B (control group) receive 10 daily sessions of 15 min manual therapy (i.e.
      massage, etc) starting from day one of radiotherapy.

      Follow-up of the patients is scheduled at 12 weeks post completion of radiotherapy incl. CT
      of the spine and physical examination.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2011</start_date>
  <completion_date type="Actual">September 2013</completion_date>
  <primary_completion_date type="Actual">September 2012</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>feasibility of isometric exercise in vertebral bony metastases</measure>
    <time_frame>12 weeks post completion of radiotherapy</time_frame>
    <description>safety and feasibility of isometric exercise in vertebral bony metastases</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>progression-free survival (PFS)</measure>
    <time_frame>2 years post completion of radiotherapy</time_frame>
    <description>PFS is assessed 2 years post completion of radiotherapy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>fracture-free survival (FFS)</measure>
    <time_frame>2 years post completion of radiotherapy</time_frame>
    <description>FFS is assessed 2 years post completion of radiotherapy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>bone density</measure>
    <time_frame>12 weeks post completion radiotherapy</time_frame>
    <description>bone density is assessed 12 weeks post completion of radiotherapy using follow-up CT scan of the spine</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pain reduction</measure>
    <time_frame>end of treatment, 12 and 24 weeks post completion of radiotherapy</time_frame>
    <description>pain is evaluated using the VAS pain scale (0-100 points) at completion and 12/ 24 weeks post completion of radiation therapy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>12 and 24 weeks post completion of therapy</time_frame>
    <description>Quality of life is assessed using the EORTC BM22 questionnaire at 12 and 24 weeks post completion of treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fatigue</measure>
    <time_frame>12 and 24 weeks post completion of therapy</time_frame>
    <description>Fatigue is assessed using the EORTC FA13 questionnaire</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Vertebral Bony Metastases</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients in arm A carry out daily physical training consisting of three different isometric exercises under the guidance and supervision of a physiotherapist. Training starts day one (first radiotherapy session), 10 daily units of 30 min each are scheduled during radiotherapy. Patients are expected to continue training until 12 weeks post completion of radiotherapy at home.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients in arm B (control group) receive 10 daily sessions of 15 min manual therapy (i.e. massage, etc) starting from day one of radiotherapy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>exercise</intervention_name>
    <description>tailored isometric physical exercise</description>
    <arm_group_label>A</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  solitary or multiple vertebral metastases

          -  thoracic spine

          -  lumbar spine

          -  sacrum

          -  indication for palliative radiation therapy

          -  age: 18 - 80 years

          -  Karnofsky index &gt; 70%

          -  bisphosphonate therapy inititated

        Exclusion Criteria:

          -  bony metastases of cervical spine or pelvis

          -  impending fracture

          -  other serious illnesses or medical conditions: therapy-refractory unstable heart
             disease, congestive heart failure NYHA °III and °IV; coagulopathies

          -  Significant neurological or psychiatric condition including dementia or seizures or
             other serious medical condition prohibiting the patient's participation in the trial
             by judgement of the investigators

          -  Legal incapacity or limited legal capacity

          -  Positive serum/ urine beta-HCG/ pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Juergen Debus, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Heidelberg University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dept of Radiation Oncology, University of Heidelberg, Germany</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>ABRAMS HL, SPIRO R, GOLDSTEIN N. Metastases in carcinoma; analysis of 1000 autopsied cases. Cancer. 1950 Jan;3(1):74-85.</citation>
    <PMID>15405683</PMID>
  </reference>
  <reference>
    <citation>Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993 Mar 3;85(5):365-76.</citation>
    <PMID>8433390</PMID>
  </reference>
  <reference>
    <citation>Berrettoni BA, Carter JR. Mechanisms of cancer metastasis to bone. J Bone Joint Surg Am. 1986 Feb;68(2):308-12.</citation>
    <PMID>3753707</PMID>
  </reference>
  <reference>
    <citation>Bubendorf L, Schöpfer A, Wagner U, Sauter G, Moch H, Willi N, Gasser TC, Mihatsch MJ. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol. 2000 May;31(5):578-83.</citation>
    <PMID>10836297</PMID>
  </reference>
  <reference>
    <citation>Cheville AL, Girardi J, Clark MM, Rummans TA, Pittelkow T, Brown P, Hanson J, Atherton P, Johnson ME, Sloan JA, Gamble G. Therapeutic exercise during outpatient radiation therapy for advanced cancer: Feasibility and impact on physical well-being. Am J Phys Med Rehabil. 2010 Aug;89(8):611-9. doi: 10.1097/PHM.0b013e3181d3e782.</citation>
    <PMID>20531162</PMID>
  </reference>
  <reference>
    <citation>Harrington KD. Impending pathologic fractures from metastatic malignancy: evaluation and management. Instr Course Lect. 1986;35:357-81.</citation>
    <PMID>3819423</PMID>
  </reference>
  <reference>
    <citation>Hochschild J. Strukturen und Funktionen begreifen. Funktionelle Anatomie Band 1 und 2, Stuttgart: Thieme</citation>
  </reference>
  <reference>
    <citation>Krempien B. Die Entstehung von Knochenschmerzen bei Knochenmetastasen und ihre Behandlung durch Bisphosphonate. Hrsg: Bartsch HH, Hornstein W: Interdisziplinäre Schmerztherapie bei Tumorpatienten, 1998</citation>
  </reference>
  <reference>
    <citation>Murnane A, Geary B, Milne D. The exercise programming preferences and activity levels of cancer patients undergoing radiotherapy treatment. Support Care Cancer. 2012 May;20(5):957-62. doi: 10.1007/s00520-011-1167-z. Epub 2011 Apr 27.</citation>
    <PMID>21523349</PMID>
  </reference>
  <reference>
    <citation>Nikander R, Sievänen H, Ojala K, Oivanen T, Kellokumpu-Lehtinen PL, Saarto T. Effect of a vigorous aerobic regimen on physical performance in breast cancer patients - a randomized controlled pilot trial. Acta Oncol. 2007;46(2):181-6.</citation>
    <PMID>17453366</PMID>
  </reference>
  <reference>
    <citation>Pilge H, Holzapfel BM, Prodinger PM, Hadjamu M, Gollwitzer H, Rechl H. [Diagnostics and therapy of spinal metastases]. Orthopade. 2011 Feb;40(2):185-93; quiz 194-5. doi: 10.1007/s00132-010-1738-6. German.</citation>
    <PMID>21271338</PMID>
  </reference>
  <reference>
    <citation>Roe JW, Ashforth KM. Prophylactic swallowing exercises for patients receiving radiotherapy for head and neck cancer. Curr Opin Otolaryngol Head Neck Surg. 2011 Jun;19(3):144-9. doi: 10.1097/MOO.0b013e3283457616. Review.</citation>
    <PMID>21430531</PMID>
  </reference>
  <reference>
    <citation>Stevinson C, Fox KR. Feasibility of an exercise rehabilitation programme for cancer patients. Eur J Cancer Care (Engl). 2006 Sep;15(4):386-96.</citation>
    <PMID>16968322</PMID>
  </reference>
  <reference>
    <citation>Verger E, Salamero M, Conill C. Can Karnofsky performance status be transformed to the Eastern Cooperative Oncology Group scoring scale and vice versa? Eur J Cancer. 1992;28A(8-9):1328-30.</citation>
    <PMID>1515244</PMID>
  </reference>
  <reference>
    <citation>Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, Zagzag D, Buechler P, Isaacs WB, Semenza GL, Simons JW. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res. 1999 Nov 15;59(22):5830-5.</citation>
    <PMID>10582706</PMID>
  </reference>
  <verification_date>August 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 2, 2011</study_first_submitted>
  <study_first_submitted_qc>August 3, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 4, 2011</study_first_posted>
  <last_update_submitted>March 19, 2014</last_update_submitted>
  <last_update_submitted_qc>March 19, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 20, 2014</last_update_posted>
  <responsible_party>
    <name_title>Prof. Dr. Dr. J. Debus</name_title>
    <organization>Dept of Radiation Oncology, University of Heidelberg, Germany</organization>
  </responsible_party>
  <keyword>bony metastases</keyword>
  <keyword>physical exercise</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasm Metastasis</mesh_term>
    <mesh_term>Neoplasms, Second Primary</mesh_term>
    <mesh_term>Bone Neoplasms</mesh_term>
    <mesh_term>Bone Marrow Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

